Search alternatives:
latent decrease » latency decreased (Expand Search), largest decrease (Expand Search), content decreased (Expand Search)
marked decrease » marked increase (Expand Search)
a latent » _ latent (Expand Search), _ patent (Expand Search)
latent decrease » latency decreased (Expand Search), largest decrease (Expand Search), content decreased (Expand Search)
marked decrease » marked increase (Expand Search)
a latent » _ latent (Expand Search), _ patent (Expand Search)
-
1
-
2
-
3
-
4
-
5
-
6
-
7
Loss of ECRG4 expression decreases neutrophil mobilization from bone marrow reserves.
Published 2024Subjects: -
8
Posterior distribution of the effect of the latent variable on the probability of seeking traditional remedies after a potential dog bite indicates a decreased likelihood of individuals seeking traditional remedies.
Published 2025“…<p>Posterior distribution of the effect of the latent variable on the probability of seeking traditional remedies after a potential dog bite indicates a decreased likelihood of individuals seeking traditional remedies.…”
-
9
Biases in larger populations.
Published 2025“…<p>(<b>A</b>) Maximum absolute bias vs the number of neurons in the population for the Bayesian decoder. …”
-
10
-
11
Group-level narrow- and broad-band spectral changes after hemispherotomy reveal a marked EEG slowing of the isolated cortex, robust across patients.
Published 2025“…This decrease was larger in the disconnected than in the contralateral cortex. …”
-
12
Raw data of the charts in Fig 5.
Published 2024“…Concurrently, venetoclax inhibited Bcl-2 upregulated by either LMP-1 or EBNA-3C. Bort/venetoclax decreased the expression of phosphorylated p65 and Bcl-2 at serine 70 thereby suppressing the NF-κB signaling pathway and promoting apoptosis, respectively. …”
-
13
Antibodies used in western blot analysis.
Published 2024“…Concurrently, venetoclax inhibited Bcl-2 upregulated by either LMP-1 or EBNA-3C. Bort/venetoclax decreased the expression of phosphorylated p65 and Bcl-2 at serine 70 thereby suppressing the NF-κB signaling pathway and promoting apoptosis, respectively. …”
-
14
Raw data of the charts in Fig 3.
Published 2024“…Concurrently, venetoclax inhibited Bcl-2 upregulated by either LMP-1 or EBNA-3C. Bort/venetoclax decreased the expression of phosphorylated p65 and Bcl-2 at serine 70 thereby suppressing the NF-κB signaling pathway and promoting apoptosis, respectively. …”
-
15
Raw data of the charts in Fig 1.
Published 2024“…Concurrently, venetoclax inhibited Bcl-2 upregulated by either LMP-1 or EBNA-3C. Bort/venetoclax decreased the expression of phosphorylated p65 and Bcl-2 at serine 70 thereby suppressing the NF-κB signaling pathway and promoting apoptosis, respectively. …”
-
16
Raw data of the charts in Fig 6.
Published 2024“…Concurrently, venetoclax inhibited Bcl-2 upregulated by either LMP-1 or EBNA-3C. Bort/venetoclax decreased the expression of phosphorylated p65 and Bcl-2 at serine 70 thereby suppressing the NF-κB signaling pathway and promoting apoptosis, respectively. …”
-
17
Raw data of the charts in Fig 2.
Published 2024“…Concurrently, venetoclax inhibited Bcl-2 upregulated by either LMP-1 or EBNA-3C. Bort/venetoclax decreased the expression of phosphorylated p65 and Bcl-2 at serine 70 thereby suppressing the NF-κB signaling pathway and promoting apoptosis, respectively. …”
-
18
-
19
-
20